TILL TRANSAKTIONER
Mat & dryck | Hälsovård

Naturex SA has acquired Swedish Oat Fiber AB

Naturex SA, the global leader in specialty plant-based natural ingredients, has acquired Swedish Oat Fiber AB, a specialized manufacturer of oat dietary fibers, oat oils and oat proteins. Financial details have not been disclosed.

Naturex sources, manufactures and markets natural specialty ingredients for the food, healthcare and cosmetic industries. Headquartered in Avignon, France, the group has experienced steadily increasing growth throughout the last 25 years. Naturex employs 1,700 people worldwide and had revenues of US$437 million in 2016.

Swedish Oat Fiber is a manufacturer with a key international position as a producer of oat beta-glucans dietary fibers, oat oils and oat proteins for the food industry, nutraceutical, cosmetic and animal feed applications. The company has 25 employees and an annual turnover of US$13.2 million.

Oaklins' teams in France and Sweden identified potential targets and advised the buyer on this transaction. This is another example of the strength of Oaklins' teams working together.

Parter

Prata med transaktionsteamet

Philippe Hermant

Senior Advisor
Paris, Frankrike
Oaklins France

Adel Koubaa

Managing Partner
Stockholm, Sverige
Oaklins Sweden

Lars Gustafsson

Partner
Stockholm, Sverige
Oaklins Sweden

Leïla Djebli

Director
Paris, Frankrike
Oaklins France

Relaterade transaktioner

Bayer AG has entered into a takeover agreement with Cara Care
Hälsovård | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Lär dig mer
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Hälsovård

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Lär dig mer
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Hälsovård

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Lär dig mer